Mohammed Qatanani
Chief Tech/Sci/R&D Officer at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 2 M $ as of 2024-04-29
Mohammed Qatanani active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 2022-08-31 | - |
Career history of Mohammed Qatanani
Former positions of Mohammed Qatanani
| Companies | Position | Start | End |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-01-31 | 2021-08-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-06-30 | 2017-12-31 |
Training of Mohammed Qatanani
| American University of Beirut | Graduate Degree |
| Baylor College of Medicine | Masters Business Admin |
Statistics
International
| United States | 5 |
| Lebanon | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Mohammed Qatanani
- Experience
